TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ardent Health Partners, Inc. ( (ARDT) ) has provided an announcement.
On November 17, 2025, Ardent Health, Inc. announced a $50 million stock repurchase program authorized by its Board of Directors. This initiative allows the company to buy back its common stock through various methods without a specified expiration date, using existing cash and cash equivalents. The program, which adheres to federal securities laws, is flexible and can be modified or terminated at any time, reflecting the company’s strategic approach to managing its capital and potentially enhancing shareholder value.
The most recent analyst rating on (ARDT) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Ardent Health Partners, Inc. stock, see the ARDT Stock Forecast page.
Spark’s Take on ARDT Stock
According to Spark, TipRanks’ AI Analyst, ARDT is a Neutral.
Ardent Health Partners, Inc. demonstrates strong financial performance and valuation, with significant growth in revenue and EBITDA. However, technical indicators show bearish momentum, and cost pressures remain a challenge. The company’s strategic initiatives for cost optimization and growth provide a positive outlook.
To see Spark’s full report on ARDT stock, click here.
More about Ardent Health Partners, Inc.
Average Trading Volume: 450,064
Technical Sentiment Signal: Sell
Current Market Cap: $1.29B
For detailed information about ARDT stock, go to TipRanks’ Stock Analysis page.